0000899243-20-024397.txt : 20200904 0000899243-20-024397.hdr.sgml : 20200904 20200904190327 ACCESSION NUMBER: 0000899243-20-024397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200904 DATE AS OF CHANGE: 20200904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201162717 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Partners Foundation, L.P. CENTRAL INDEX KEY: 0001783583 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201162718 BUSINESS ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Umari Abude CENTRAL INDEX KEY: 0001783582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201162719 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZEIN YOUSSEF EL CENTRAL INDEX KEY: 0001193366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201162720 MAIL ADDRESS: STREET 1: HYBRIDON INC STREET 2: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-12 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783583 Pillar Partners Foundation, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783582 Umari Abude PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001193366 ZEIN YOUSSEF EL PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 Common Warrants 2020-05-12 4 P 0 3039514 A Common Stock 3039514 3039514 I By Pillar Partners Foundation, L.P. See Footnote On April 7, 2020, upon the consummation of a private placement of the Issuer, Pillar Partners Foundation, L.P. ("Pillar Foundation"), acquired, in the Private Placement, 3,039,514 shares of common stock (the "Pillar Foundation Shares") as well as warrants to purchase 3,039,514 shares of common stock of the Issuer (the "Pillar Foundation Warrants"). Each Pillar Foundation Share and the associated Pillar Foundation Warrant had a combined purchase price of $1.645, which combined purchase price included $0.125 for each share of common stock underlying each Pillar Foundation Warrant. The exercise price of each Pillar Foundation Warrant is $2.28 per share, subject to adjustment pursuant to the terms of the Pillar Foundation Warrants and the Pillar Foundation Warrants expire 3 years from their issuance date. The Pillar Foundation Warrants became exercisable on May 12, 2020 following receipt of shareholder approval for the sufficient increase in the Issuer's authorized shares of common stock to cover the exercise of the Pillar Foundation Warrants. The Pillar Foundation Warrants are exercisable, to the extent that after giving effect to such exercise the holders thereof and their affiliates would beneficially own, for purposes of Rule 13d-3 under the Securities Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer. Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals I, L.P., Pillar Pharmaceuticals II, L.P., Pillar Pharmaceuticals III, L.P., Pillar Pharmaceuticals IV, L.P., Pillar Pharmaceuticals V, L.P., Pillar Pharmaceuticals 6, L.P. and Pillar Foundation (collectively, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2020-09-04 Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person 2020-09-04 /s/ Abude Umari 2020-09-04 /s/ Youssef El Zein 2020-09-04